Acerus to Report 2018 Financial Results and Host Investor Call
TORONTO--(BUSINESS WIRE)--Feb 26, 2019--Acerus Pharmaceuticals Corporation (TSX:ASP) will announce financial results for the three and twelve month periods ending December 31, 2018 on Tuesday, March 05, 2019 before market opens. The company will host a conference call on Tuesday, March 05, 2019 at 8:30 a.m. Eastern Time.
To access the call live, please dial 647-484-0475 or 1-888-220-8451. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Tuesday, March 12, 2019 by dialing 905-694-9451 or 1-800-408-3053, using access code:7172777#.
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve patient experience, with a primary focus in the field of men’s and women’s health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.
Acerus’ shares trade on Toronto Stock Exchange under the symbol “ASP”. For more information, visit www.aceruspharma.com and follow us on Twitter and Linkedin.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190226005120/en/
CONTACT: Ed Gudaitis
President & CEO
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES FINANCE
SOURCE: Acerus Pharmaceuticals Corporation
Copyright Business Wire 2019.
PUB: 02/26/2019 07:00 AM/DISC: 02/26/2019 07:01 AM